HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
Press releases
October 10, 2023
Our new CSR strategy
Javené, October 9, 2023
HTL, pioneer in the development and production of innovative pharmaceutical-grade biopolymers, announces its new corporate social responsibility (CSR) strategy. It aims to accelerate the company’s commitment to its entire ecosystem and transform its activity into a positive and sustainable force.
The strategy includes 19 commitments, divided into three priority areas: responsibility to preserve the environment, exemplarity with employees, and citizenship with civil society.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Articles October 29, 2025HTL Inside Webinar: a success that boosts our visibility in Asia
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
-
Articles October 9, 2025HTL Biotechnology rallies for Pink October 2025
This October, HTL Biotechnology turned pink to support breast cancer prevention.
-
Articles September 19, 2025HTL Biotechnology wins the Responsible Care 2025 Award
HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.